跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 41,533 条关于
“mixed phenotype acute leukemia”
全部
41,533
临床试验
36,428
药物
383
机构
42
资讯
4,680
3年前
Revumenib Shows Promise in Phase 1 Trial for KMT2A-Rearranged and NPM1-Mutated Acute Leukemia
去年
Orca Bio's Phase III Precision-T Study Shows Promise for Novel T-Cell Immunotherapy in Blood Cancers
去年
Orca-T Cell Therapy Shows Superior Outcomes in Phase 3 Trial for Blood Cancer Patients
去年
Revumenib Demonstrates Sustained Responses in Relapsed/Refractory KMT2Ar Acute Leukemia
去年
FDA Updates: Approvals and Designations in Leukemia, Prostate Cancer, and Melanoma
8个月前
Orca Bio Secures $250M Financing to Prepare for Orca-T Commercial Launch Ahead of April 2026 FDA Decision
9个月前
Phase 2 EndRAD Study Shows Non-TBI Conditioning Maintains Efficacy in Pediatric B-ALL Transplant
8个月前
Syndax Partners with WODA to Expand Global Access to Revuforj Through Multi-Regional Managed Access Program
9个月前
Menin Inhibitors Show Promise as Targeted Therapy for Aggressive KMT2A-Rearranged Acute Leukemia
去年
Syndax Highlights Revumenib and Niktimvo Progress in Q3 2024 Update
第 1 页，共 468 页
上一页
下一页
